WALTHAM, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its first quarter 2019 financial results on Wednesday, May 8, 2019. The Company will host a conference call and live audio webcast at 8:00 a.m. ET that day to discuss the results and provide a company update.

Conference Call Information:
Date: Wednesday, May 8, 2019
Time: 8:00 a.m. ET
Domestic Dial-In Number: (855) 404-2458
International Dial-In Number: (346) 406-0961
Conference ID: 5856126

A replay of the conference call/webcast will be available from Wednesday, May 8, 2019 at 11:00 a.m. ET and will be archived on the Company's website for 90 days. To access the replay, dial (855) 859-2056 U.S. or (404) 537-3406 for International, using conference ID number 5856126.

The live audio webcast of the call can be accessed from the Investors section of the Company’s website, https://ir.radiuspharm.com/events-and-presentations. The full text of the announcement and financial results will also be available on the Company’s website.

About Radius

Radius is a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics in the areas of osteoporosis and oncology. For more information, please visit www.radiuspharm.com.

Investor & Media Relations Contact:

Elhan Webb, CFA
Email: ewebb@radiuspharm.com  
Phone: 617-551-4011